This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

SARS-CoV-2 characterized ePBMC®

We offer PBMC from subjects who verifiably have or have not been infected by SARS-CoV-2.

Product 1 – Subjects collected in the Pre-COVID era (11/2019) that are immunologically uncharacterized (negative controls)

≥10 million cells per vial
$ 160/vial

Product 2 – Subjects with prior (PCR-verified) infection with SARS-CoV-2, collected after convalescence and characterized for T and/or B cell reactivity against SARS-CoV-2 antigens (positive controls)

≥10 million cells per vial
$ 560/vial

Product 3 – Subjects collected in the Post-COVID era that exhibit memory B cell reactivity against SARS-CoV-2 Nucleocapsid or Spike antigens, suggesting past SARS-CoV-2 infection. (see reference)

≥10 million cells per vial
$ 360/vial

For custom concentrations and volume discounts, please inquire at

More Information


These cryopreserved PBMC are ideal for any applications that requires samples from subjects who verifiably have or have not been infected by SARS-CoV-2.